These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21638910)

  • 21. Hypouricemia in severely disabled children II: influence of elemental enteral nutrition on the serum uric acid levels.
    Yoshikawa H; Yamazaki S; Abe T
    Brain Dev; 2004 Jan; 26(1):43-6. PubMed ID: 14729414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.
    Wang C; Zhou Y; Song L; Deng Z; Fang W
    Front Med (Lausanne); 2022; 9():945244. PubMed ID: 36186816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible Fanconi syndrome associated with valproate therapy.
    Lande MB; Kim MS; Bartlett C; Guay-Woodford LM
    J Pediatr; 1993 Aug; 123(2):320-2. PubMed ID: 7688423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy].
    Ono H
    No To Hattatsu; 2009 Sep; 41(5):363-5. PubMed ID: 19764458
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of sodium valproate on the renal function of children with epilepsy.
    Knights MJ; Finlay E
    Pediatr Nephrol; 2014 Jul; 29(7):1131-8. PubMed ID: 23720013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Valproate induced parkinsonism].
    Park-Matsumoto YC; Tazawa T
    No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant-induced rickets and nephrocalcinosis.
    Lau KK; Papneja K
    BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature.
    Gerstner T; Büsing D; Bell N; Longin E; Kasper JM; Klostermann W; Hebing B; Hanefeld F; Eckel U; Hoffmann R; Bettendorf U; Weidner B; Wiemer-Kruel A; Brockmann K; Neumann FW; Sandrieser T; Wolff M; König S
    J Gastroenterol; 2007 Jan; 42(1):39-48. PubMed ID: 17322992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal injury from valproic acid: case report and literature review.
    Zaki EL; Springate JE
    Pediatr Neurol; 2002 Oct; 27(4):318-9. PubMed ID: 12435575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological fracture and pyogenic osteomyelitis in a patient with type 2 Gaucher disease.
    Hayashi A; Kawakita R; Kumada T; Nozaki F; Hiejima I; Miyajima T; Kusunoki T; Fujii T
    Brain Dev; 2014 Oct; 36(9):830-3. PubMed ID: 24412634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)--a study from tertiary care referral university hospital, north India.
    Mehndiratta MM; Mehndiratta P; Phul P; Garg S
    J Pak Med Assoc; 2008 Nov; 58(11):627-31. PubMed ID: 19024136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypophosphatemia is a common complication in severely disabled individuals with neurological disorders and is caused by infection, refeeding and Fanconi syndrome.
    Saito Y; Aoki Y; Takeshita E; Saito T; Sugai K; Komaki H; Nakagawa E; Ishiyama A; Takanoha S; Wada S; Sasaki M
    Brain Dev; 2014 Nov; 36(10):878-83. PubMed ID: 24360095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute pancreatitis coincident with valproate use: a critical review.
    Pellock JM; Wilder BJ; Deaton R; Sommerville KW
    Epilepsia; 2002 Nov; 43(11):1421-4. PubMed ID: 12423394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproic acid-induced encephalopathy in very long course treated patients.
    Rousseau MC; Montana M; Villano P; Catala A; Blaya J; Valkov M; Allouard Y; Bugni E
    Brain Inj; 2009 Nov; 23(12):981-4. PubMed ID: 19831495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.